These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31203501)

  • 1. Comparison of Venous Thromboembolism Prophylactic Measures Post Coronary Artery Bypass Graft Surgery.
    Wilsey HA; Pandya K; Beavers C; Xiaoshu L; Ather A
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):589-595. PubMed ID: 31203501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.
    Veeranki SP; Xiao Z; Levorsen A; Sinha M; Shah BR
    Am J Cardiovasc Drugs; 2021 Jul; 21(4):443-452. PubMed ID: 33313988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients.
    DeBiase C; Giuliano CA; Doshi M; Ganoff M; Alexander Paxton R
    Pharmacotherapy; 2021 May; 41(5):424-429. PubMed ID: 33641194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.
    Samuel S; Li W; Dunn K; Cortes J; Nguyen T; Moussa D; Kumar A; Dao T; Beeson J; Choi HA; McCullough LD
    J Thromb Thrombolysis; 2023 May; 55(4):617-625. PubMed ID: 37029256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
    Samuel S; To C; Ling Y; Zhang K; Jiang X; Bernstam EV
    J Thromb Thrombolysis; 2023 Apr; 55(3):439-448. PubMed ID: 36624202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.
    Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
    J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients.
    Laporte S; Liotier J; Bertoletti L; Kleber FX; Pineo GF; Chapelle C; Moulin N; Mismetti P
    J Thromb Haemost; 2011 Mar; 9(3):464-72. PubMed ID: 21232002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
    Pariser JJ; Pearce SM; Anderson BB; Packiam VT; Prachand VN; Smith ND; Steinberg GD
    J Urol; 2017 Feb; 197(2):302-307. PubMed ID: 27569434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
    Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
    Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients with renal impairment.
    Elsaid KA; Collins CM
    Am J Health Syst Pharm; 2012 Mar; 69(5):390-6. PubMed ID: 22345418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH).
    Kananeh MF; Fonseca-Paricio MJ; Liang JW; Sullivan LT; Sharma K; Shah SO; Vibbert MD
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105476. PubMed ID: 33253987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery.
    Kulik A; Rassen JA; Myers J; Schneeweiss S; Gagne J; Polinski JM; Liu J; Fischer MA; Choudhry NK
    Circ Cardiovasc Interv; 2012 Aug; 5(4):590-6. PubMed ID: 22739788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.
    Renda G; Di Pillo R; D'Alleva A; Sciartilli A; Zimarino M; De Candia E; Landolfi R; Di Giammarco G; Calafiore A; De Caterina R
    Haematologica; 2007 Mar; 92(3):366-73. PubMed ID: 17339186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and efficacy for different regimens of pharmaco-prophylaxis among severely burned patients: a randomized controlled trial.
    Al Sulaiman KA; Al-Ramahi G; Aljuhani O; Al-Joudi K; Alhujayri AK; Al-Shomer F; Silas J; Al Dabbagh T; Al Harbi S; AlDekhayel S; Eldali A; Alqahtani R; Vishwakarma R; Al-Dorzi HM
    Eur J Trauma Emerg Surg; 2024 Apr; 50(2):567-579. PubMed ID: 38240791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term therapy with enoxaparin or unfractionated heparin for venous thromboembolism in hospitalized patients: utilization study and cost-minimization analysis.
    Argenta C; Ferreira MA; Sander GB; Moreira LB
    Value Health; 2011; 14(5 Suppl 1):S89-92. PubMed ID: 21839908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
    Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
    Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.
    Betthauser K; Pope H; Gowan M; Human T
    Neurocrit Care; 2017 Aug; 27(1):96-102. PubMed ID: 28097621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.